Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01849848
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AM9 | 6-(2,6-dimethylphenyl)-2-{[4-(4- methylpiperazin-1-yl)phenyl]amino}pyrimido[5',4':5,6]pyrimido[1,2- a]benzimidazol-5(6H)-one | A | 3BYO | 0.74 | |
LIE | 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)- 9-ISOPROPYL-9H-PURIN-8-AMINE | A | 2GTN | 0.7 | |
AAI | trans-4-(7-carbamoyl-1H-benzimidazol- 2-yl)-1-propylpiperidinium | A | 2RCW | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KQO | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H29 | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1NUQ | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1WXG | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KAQ | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1EE1 | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D | 3E27 | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1XQD | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H2A | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1IFX | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1XNG | 0.73 | |
CBB | 1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE- 2-CARBOXYLIC ACID 3-CARBAMIMIDOYL- BENZYLESTER | B | 1LPK | 0.71 | |
AGN | A | 1GNP | 0.7 | ||
3B9 | N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin- 7-yl)-2-methylpropyl]-4-phenoxybenzamide | A | 3BAC | 0.7 | |
3B9 | N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin- 7-yl)-2-methylpropyl]-4-phenoxybenzamide | A | 3BA9 | 0.7 | |
DVP | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D,E,F, G,H | 3H4V | 0.74 | |
CKR | 6-amino-2-[(2-morpholin-4-ylethyl)amino]- 3,7-dihydro-8H-imidazo[4,5-g]quinazolin- 8-one | A | 3C2N | 0.71 | |
E89 | 6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]- 1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN- 8-ONE | A,D | 1Y5X | 0.71 | |
PSB | 3-(5-AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5- D]PYRIMIDIN-2-YL)-N-[2-(2-(HYDROXYMETHYL- PHENYLSULFANYL)-BENZYL]-BENZAMIDE | A | 1RSD | 0.72 | |
PMD | [N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]- DIBENZ[B,F]AZEPINE | A | 1KLK | 0.7 | |
OQB | 4-OXO-3-[(6-{[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-METHYL}-PYRIDINE- 3-CARBONYL)-AMINO]-BUTYRIC ACID | A | 1RWW | 0.7 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.71 | |
653 | 5-(2-AMINOETHYL)-3-{5-[AMINO(IMINIO)METHYL]- 1H-BENZIMIDAZOL-2-YL}-1,1'-BIPHENYL- 2-OLATE | A | 1O38 | 0.7 | |
653 | 5-(2-AMINOETHYL)-3-{5-[AMINO(IMINIO)METHYL]- 1H-BENZIMIDAZOL-2-YL}-1,1'-BIPHENYL- 2-OLATE | A | 1O37 | 0.7 | |
BBZ | 2'-(4-DIMETHYLAMINOPHENYL)-5-(4- METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | B | 447D | 0.7 | |
BBZ | 2'-(4-DIMETHYLAMINOPHENYL)-5-(4- METHYL-1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | B | 1QV8 | 0.7 | |
711 | 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN- 4-YL]OXY]-2-METHYL-BENZIMIDAZOL- 1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID | A | 1QBO | 0.73 | |
NBD | N6-BENZYL-NICOTINAMIDE-ADENINE- DINUCLEOTIDE | A,B,C,D | 1GYQ | 0.7 | |
FXG | N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide | A | 3DAJ | 0.71 | |
S03 | 1-{4-[4-AMINO-5-(3-METHOXYPHENYL)- 7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL]BENZYL}PIPERIDIN- 4-OL | A,B | 1YOL | 0.7 | |
ONA | A,C | 2GVZ | 0.76 | ||
DD1 | 5-{[1-(2-fluorobenzyl)piperidin- 4-yl]methoxy}quinazoline-2,4-diamine | A | 3BL7 | 0.71 | |
FR4 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6- [(3-PHENYLPROPANOYL)AMINO]-1H-INDOL- 1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1UML | 0.7 | |
I4A | 5-(3-carbamoylbenzyl)-5,6,7,8,9,10- hexahydrocyclohepta[b]indole-4- carboxylic acid | A | 3FR5 | 0.7 | |
T87 | [(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-1-METHYL-1H-BENZOIMIDAZOL- 5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL- METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER | B,C | 1G30 | 0.71 | |
T87 | [(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-1-METHYL-1H-BENZOIMIDAZOL- 5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL- METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER | A | 1G2L | 0.71 | |
T87 | [(1-{2[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-1-METHYL-1H-BENZOIMIDAZOL- 5-YL}-CYCLOPROPYL)-PYRIDIN-2-YL- METHYLENEAMINOOXY]-ACETIC ACID ETHYL ESTER | A | 1OYQ | 0.71 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.7 | |
R86 | 2-{(2R)-4-[2-(1H-IMIDAZOL-1-YL)- 6-METHYLPYRIMIDIN-4-YL]-1-ISOBUTYRYLPIPERAZIN- 2-YL}-N-[2-(4-METHOXYPHENYL)ETHYL]ACETAMIDE | A | 2ORP | 0.7 | |
FE1 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN- 6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE- 4-CARBOXYLATE | A,B,C,D | 2QHX | 0.75 | |
PT1 | PTEROIC ACID | A,B | 1TX0 | 0.72 | |
PT1 | PTEROIC ACID | A | 1BR6 | 0.72 | |
PT1 | PTEROIC ACID | A,B | 1HWP | 0.72 | |
CMF | 3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL- 2-OXOETHYL)-2-PHENYL-1H-INDOLE- 6-CARBOXYLIC ACID | A | 2BRK | 0.71 | |
E97 | [3-(4-{2'-[4-(3-DIMETHYLAMINO-PROPOXY)- PHENYL]-3H,3'H-[5,5']BIBENZOIMIDAZOLYL- 2-YL}-PHENOXY)-PROPYL]-DIMETHYL- AMINE | A | 1FTD | 0.71 | |
T12 | 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]- 1H-BENZIMIDAZOL-5-YL PIVALATE | A,B,C,D | 2NRU | 0.72 | |
GRD | benzyl (S)-1-((2S,3S)-1-(3-(6-amino- 9H-purin-9-yl)propylamino)-2-hydroxy- 1-oxopentan-3-ylamino)-4-methyl- 1-oxopentan-2-ylcarbamate | A | 2R9C | 0.72 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z8C | 0.7 | |
S91 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENYL]ACETIC ACID | A | 2Z7L | 0.7 | |
PU7 | 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)- 9H-PURIN-6-YLAMINE | A | 1UYC | 0.72 | |
3GO | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- (quinolin-6-ylmethylamino)purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZM | 0.73 | |
PVB | PURVALANOL | A | 1CKP | 0.73 | |
PVB | PURVALANOL | A,B | 1V0P | 0.73 | |
GS2 | 2-[(2-{[1-(N,N-dimethylglycyl)- 5-methoxy-1H-indol-6-yl]amino}- 7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]- 6-fluoro-N-methylbenzamide | A | 3EKK | 0.71 | |
PU5 | 9-BUTYL-8-(3-METHOXYBENZYL)-9H- PURIN-6-AMINE | A | 1UY8 | 0.72 | |
A45 | 3-(5-AMINO-7-HYDROXY-[1,2,3]TRIAZOLO[4,5- D]PYRIMIDIN-2-YL)-BENZOIC ACID | A | 1RRI | 0.73 | |
00A | 5'-O-[(S)-{[(4-chlorophenyl)carbonyl]oxy}(hydroxy)phosphoryl]adenosine | X | 3CW8 | 0.7 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,C,D,E,F | 3E8C | 0.72 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E88 | 0.72 | |
090 | N-(2,3-DIHYDRO-7,8-DIMETHOXYIMIDAZO[1,2- C] QUINAZOLIN-5-YL)NICOTINAMIDE | A | 2CHX | 0.72 | |
NXX | A,B,C,D | 3DLA | 0.73 | ||
NXX | A,B,C | 2QTR | 0.73 | ||
312 | 2-(5-{5-[AMINO(IMINIO)METHYL]-1H- BENZIMIDAZOL-2-YL}-2'-METHOXY-6- OXIDO-1,1'-BIPHENYL-3-YL)SUCCINATE | A | 1O2Z | 0.71 | |
DFW | N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN- 4-YL)GLYCINE | A | 2BRH | 0.7 | |
HET | 3-[2-(2-CYCLOPENTYL-6-{[4-(DIMETHYLPHOSPHORYL)PHENYL]AMINO}- 9H-PURIN-9-YL)ETHYL]PHENOL | A | 2BDJ | 0.71 | |
PU0 | 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)- 2-FLUORO-9H-PURIN-6-YLAMINE | A | 1UYH | 0.72 | |
979 | 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3- D]PYRIMIDIN-4-AMINE | A | 2OF4 | 0.71 | |
7CS | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT- 3-YL 1H-PYRROLO[2,3-B]PYRIDINE- 3-CARBOXYLATE | A | 2QHM | 0.75 | |
RO2 | 3-[5-[5-(4-METHYL-PIPERAZIN-1-YL)- 1H-IMIDAZO[4,5-B]PYRIDIN-2-YL]- BENZIMIDAZOL-2-YL]-PHENOL | A | 303D | 0.7 | |
RO2 | 3-[5-[5-(4-METHYL-PIPERAZIN-1-YL)- 1H-IMIDAZO[4,5-B]PYRIDIN-2-YL]- BENZIMIDAZOL-2-YL]-PHENOL | A | 302D | 0.7 | |
2IG | 6-ETHYL-5-[9-(3-METHOXYPROPYL)- 9H-CARBAZOL-2-YL]PYRIMIDINE-2,4- DIAMINE | A,B | 2G1O | 0.73 | |
356 | 8-[(3R)-3-Aminopiperidin-1-yl]- 7-but-2-yn-1-yl-3-methyl-1-[(4- methylquinazolin-2-yl)methyl]-3,7- dihydro-1H-purine-2,6-dione | A,B | 2RGU | 0.73 | |
N41 | 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN- 2-YLAMINO)--BENZAMIDE | A,B,C,D | 1OIY | 0.72 | |
607 | 2-(2'-AMINO-5-{5-[AMINO(IMINIO)METHYL]- 1H-BENZIMIDAZOL-2-YL}-6-OXIDO-1,1'- BIPHENYL-3-YL)SUCCINATE | A | 1O36 | 0.71 | |
199 | N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]- 1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE | A | 1ZYS | 0.7 | |
PRD | N6-(2,5-DIMETHOXY-BENZYL)-N6-METHYL- PYRIDO[2,3-D]PYRIMIDINE-2,4,6-TRIAMINE | A | 1BOZ | 0.71 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.73 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.73 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,E,I,L,P | 3E8E | 0.73 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E8D | 0.73 | |
COG | 2,4-DIAMINO-6-[N-(2',5'-DIMETHOXYBENZYL)- N-METHYLAMINO]QUINAZOLINE | A | 1LY3 | 0.72 | |
PU4 | 9-BUTYL-8-(4-METHOXYBENZYL)-9H- PURIN-6-AMINE | A | 1UY7 | 0.72 | |
BZC | A | 1EFY | 0.73 | ||
FR5 | 1-((1R)-1-(HYDROXYMETHYL)-3-(6- ((3-(1-METHYL-1H-BENZIMIDAZOL-2- YL)PROPANOYL)AMINO)-1H-INDOL-1- YL)PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDZ | 0.71 | |
CK9 | 2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}- 9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL | X | 2A0C | 0.7 | |
PUZ | 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO- 9-PENT-9H-PURIN-6-YLAMINE | A | 1UYI | 0.71 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.8 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A,B | 403D | 0.73 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A | 129D | 0.73 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A,B | 130D | 0.73 | |
HT1 | 2'-(4-ETHOXYPHENYL)-5-(4-METHYL- 1-PIPERAZINYL)-2,5'-BI-BENZIMIDAZOLE | A | 3F8C | 0.73 | |
IQA | (5-OXO-5,6-DIHYDRO-INDOLO[1,2-A]QUINAZOLIN- 7-YL)-ACETIC ACID | A | 1OM1 | 0.74 | |
C24 | 3-({2-[(4-CARBAMIMIDOYL-PHENYLAMINO)- METHYL]-3-METHYL-3H-BENZOIMIDAZOLE- 5-CARBONYL}-PYRIDIN-2-YL-AMINO)- PROPIONIC ACID ETHYL ESTER | B,C | 1KTS | 0.76 | |
1BM | 3-{[2-(1H-BENZIMIDAZOL-1-YL)-6- {[2-(DIETHYLAMINO)ETHYL]AMINO}PYRIMIDIN- 4-YL]AMINO}-4-METHYLPHENOL | A | 2HK5 | 0.72 | |
MTX | METHOTREXATE | A,B | 1DRB | 0.7 | |
MTX | METHOTREXATE | A,B,C,D | 2C7V | 0.7 | |
MTX | METHOTREXATE | A | 1U70 | 0.7 | |
MTX | METHOTREXATE | A,B,C,D | 1MXF | 0.7 | |
MTX | METHOTREXATE | A | 2QK8 | 0.7 | |
MTX | METHOTREXATE | A,B | 1RB3 | 0.7 | |
MTX | METHOTREXATE | A,B | 1DHJ | 0.7 | |
MTX | METHOTREXATE | A | 3DAU | 0.7 | |
MTX | METHOTREXATE | A | 1U72 | 0.7 | |
MTX | METHOTREXATE | A,B | 2DRC | 0.7 | |
MTX | METHOTREXATE | A,B | 1D1G | 0.7 | |
MTX | METHOTREXATE | A,B | 1DDR | 0.7 | |
MTX | METHOTREXATE | A,B | 1E7W | 0.7 | |
MTX | METHOTREXATE | A | 1RX3 | 0.7 | |
MTX | METHOTREXATE | A | 3DFR | 0.7 | |
MTX | METHOTREXATE | A,B,C,D | 1P33 | 0.7 | |
MTX | METHOTREXATE | A | 3DAT | 0.7 | |
MTX | METHOTREXATE | A,B | 1DHI | 0.7 | |
MTX | METHOTREXATE | A,B | 1TDR | 0.7 | |
MTX | METHOTREXATE | A,B | 1DRA | 0.7 | |
MTX | METHOTREXATE | A | 3EIG | 0.7 | |
MTX | METHOTREXATE | A | 3CD2 | 0.7 | |
MTX | METHOTREXATE | A | 1AO8 | 0.7 | |
MTX | METHOTREXATE | A | 1DF7 | 0.7 | |
MTX | METHOTREXATE | A | 1DLS | 0.7 | |
MTX | METHOTREXATE | A | 1RG7 | 0.7 | |
MTX | METHOTREXATE | A | 1RH3 | 0.7 | |
MTX | METHOTREXATE | A,B | 4DFR | 0.7 | |
MTX | METHOTREXATE | A | 1RA3 | 0.7 | |
MTX | METHOTREXATE | A,B | 1DDS | 0.7 | |
MTX | METHOTREXATE | A | 1DRE | 0.7 | |
MTX | METHOTREXATE | A,B | 1AXW | 0.7 | |
MTX | METHOTREXATE | A | 3CL9 | 0.7 | |
MTX | METHOTREXATE | A,B | 3DRC | 0.7 | |
MTX | METHOTREXATE | A,B,C,D,E | 2OIP | 0.7 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.79 |